Cancer Therapy News and Research

RSS

Study: Nearly half of cancer patients who enter a tobacco treatment program quit smoking

In the largest smoking cessation study of cancer patients to date, researchers from The University of Texas MD Anderson Cancer Center found that comprehensive tobacco treatment can help cancer patients successfully quit and abstain from smoking.

27 Sep 2019

Novel nanogels could precisely deliver therapeutic treatments to cancer patients

Researchers at The University of Texas at Austin have developed new guidelines for fabricating nanoscale gel materials, or nanogels, that can deliver numerous therapeutic treatments to treat cancer in a precise manner.

27 Sep 2019

Stem cells lost in freezer malfunction: hospital apologizes and offers full support

Los Angeles hospital has apologized and offered full support after stem cells perish in fridge malfunction.

27 Sep 2019

Lumpectomy is less invasive surgery and requires no hospitalization, shows study

It is well established that breast conservation, which involves the removal of a breast cancer along with a small rim of normal breast tissue around it and is followed by radiation therapy, is at least as effective as mastectomy (removal of the whole breast) for the treatment of early breast cancer.

27 Sep 2019

High-dose radiation effective for men whose prostate cancer has spread, trial shows

A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy.

26 Sep 2019

UCLA researchers identify new drug delivery pathway to stop tumor growth

Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth and keep cancer from coming back in mice.

25 Sep 2019

Men with prostate cancer want access to female doctors

Malecare, America’s largest men’s cancer support network, this week announced the world’s first prostate cancer patient conference to feature an all-female faculty featuring twelve of the U.S.A.’s top prostate cancer clinicians

25 Sep 2019

Targeting cancer patients' mindsets could improve their health and well-being

A diagnosis of cancer can cause significant emotional burden for patients and their families. The turmoil may persist throughout treatment and even years into survivorship.

25 Sep 2019

Cryoablation procedure could be an alternative to surgery for breast cancer

When Jeanne Anderson was diagnosed with breast cancer three years ago, the Beverly Hills resident underwent a course of chemotherapy to shrink the tumors in preparation for surgery.

24 Sep 2019

Wake Forest Baptist receives multimillion-dollar grant for innovative cancer care research

For the second time in five years, Wake Forest Baptist Health has been recognized for its expertise in conducting innovative cancer care research by the National Cancer Institute's Community Oncology Research Program with a multimillion-dollar grant.

23 Sep 2019

Light-activated metal compound cuts off cancer cell's 'power source'

A space-age metal that formed part of the asteroid that destroyed the dinosaurs could provide a new method of treating cancer tumors selectively using light.

23 Sep 2019

Version of an antibiotic drug extends survival in mice with lethal pediatric brain tumors

Versions of an antibiotic drug called DON first isolated from soil bacteria more than 60 years ago have shown promising signs of extending survival in mice models of especially lethal pediatric brain tumors marked by the high expression of a cancer-causing gene known as the MYC oncogene, according to results of two studies from researchers at the Johns Hopkins Kimmel Cancer Center.

23 Sep 2019

UTHealth's innovative cancer-fighting projects receive $11 million CPRIT funding

Five innovative cancer-fighting projects at The University of Texas Health Science Center at Houston received just over $11 million during the latest round of grants awarded by the Cancer Prevention and Research Institute of Texas

21 Sep 2019

Mitochondrial fission factor could represent a promising target for cancer therapy

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.

20 Sep 2019

Early palliative care linked to better survival in patients with advanced lung cancer

Early palliative care is associated with better survival in patients with advanced lung cancer, according to a study by VA Portland Health Care System and Oregon Health and Science University researchers.

19 Sep 2019

New protein could offer a fresh target for cancer treatment

A study has revealed a drug target called the mitoNEET cell protein, which determines how materials are transported from the mitochondria to the rest of the cell.

19 Sep 2019

Researchers discover how cancer cells can trigger chronic muscle wasting condition

A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting and trigger a chronic, serious condition.

19 Sep 2019

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.

19 Sep 2019

NUS chemists develop new anti-cancer drug with less renal toxicity

A team of pharmacists and chemists from the National University of Singapore has developed a new anti-cancer drug that has less toxic effects to the kidneys.

18 Sep 2019

Cancer Therapy News and Research

Study: Nearly half of cancer patients who enter a tobacco treatment program quit smoking

Novel nanogels could precisely deliver therapeutic treatments to cancer patients

Stem cells lost in freezer malfunction: hospital apologizes and offers full support

Lumpectomy is less invasive surgery and requires no hospitalization, shows study

High-dose radiation effective for men whose prostate cancer has spread, trial shows

UCLA researchers identify new drug delivery pathway to stop tumor growth

Men with prostate cancer want access to female doctors

Targeting cancer patients' mindsets could improve their health and well-being

Cryoablation procedure could be an alternative to surgery for breast cancer

Wake Forest Baptist receives multimillion-dollar grant for innovative cancer care research

Light-activated metal compound cuts off cancer cell's 'power source'

Version of an antibiotic drug extends survival in mice with lethal pediatric brain tumors

UTHealth's innovative cancer-fighting projects receive $11 million CPRIT funding

Mitochondrial fission factor could represent a promising target for cancer therapy

Early palliative care linked to better survival in patients with advanced lung cancer

New protein could offer a fresh target for cancer treatment

Researchers discover how cancer cells can trigger chronic muscle wasting condition

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

NUS chemists develop new anti-cancer drug with less renal toxicity

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News